Skip to main content
    I

    Immunocore Holdings Ltd (IMCR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $27.81
    -1.07 (-3.71%)

    Market Cap: $1.55B

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Immunocore Holdings Ltd (IMCR) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Immunocore Holdings (IMCR) has a market cap of $1.55B. It has 51.56M shares outstanding.

    Total Valuation

    Market Cap$1.55B
    Latest price (Nov 17, 2026)$27.81

    Key Dates

    The next earnings report is expected on Feb 23, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 23, 2027 (expected)
    Last Earnings DateNov 6, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.15% in the quarter ended Sep 30, 2026 and shrank 1.19% a year over 2 years.

    Shares Outstanding51.56M
    Shares Change (YoY)+2.29%
    Shares Change (QoQ)+1.15%
    Share Count Growth (2Y CAGR)-1.19%

    Valuation Ratios

    Sales and book value multiples are 2.7x and 3.4x. Its year-end P/S ranged from 3.3x to 39.7x from 2021 to 2025.

    P/S Ratio2.7x
    P/B Ratio3.4x

    Valuation history and multiples

    Price Statistics

    The stock is down 22.64% over 52 weeks and trades 9.62% below its 50-day average.

    Beta (1Y)0.65
    52-Week Change-22.64%
    1-Month Change-6.80%
    3-Month Change-24.55%
    6-Month Change-3.87%
    5-Year Change-20.85%
    Total Return (1Y)-22.64%
    Total Return (3Y CAGR)-16.01%
    Total Return (5Y CAGR)-6.26%
    Return vs SPY (1Y)-38.49%
    Max Drawdown (1Y)-30.90%
    Max Drawdown (3Y)-67.45%
    Sharpe Ratio (1Y)-0.84
    Correlation with SPY (1Y)0.24
    50-Day Average$30.77
    200-Day Average$31.54
    52-Week Range$27.50 to $40.71
    RSI (14 Days)37.6
    Average Volume (20 Days)501.08K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 4.62x current liabilities, and total debt is 0.94x shareholder equity.

    Current Ratio4.62x
    Quick Ratio4.59x
    Debt / Equity0.94x
    Debt / EBITDA613.30x
    Interest Coverage-0.29x

    Returns and Efficiency

    Return on invested capital is -0.51% over the last 12 months, against a 5-year average of -15.13%.

    Return on Assets (ROA)-3.42%
    Return on Invested Capital (ROIC)-0.51%
    ROIC (5Y Average)-15.13%
    Inventory Turnover0.71x
    Receivables Turnover5.01x
    Cash Conversion Cycle-1036 days

    Scores

    IMCR has an Altman Z-Score of 1.53, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score1.53
    Altman Z ZoneDistress
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Peer Position

    Against 7 similar companies, IMCR has the 6th highest P/S.

    P/S Ratio2.7x vs 13.1x median
    ROIC-0.51% vs -59.97% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About IMCR

    What is IMCR's market cap?

    Immunocore Holdings has a market cap of $1.55B.

    How many shares of IMCR are outstanding?

    Immunocore Holdings has 51.56M shares outstanding. The count is up 2.29% from a year earlier.

    Does IMCR pay a dividend?

    No. Immunocore Holdings does not pay a dividend.